Integrative Multi-Omics in Glaucoma: Defining Mechanistic Axes and Enabling Precision Management

Invest Ophthalmol Vis Sci. 2026 Nov 2;67(13):39. doi: 10.1167/iovs.67.13.39. ABSTRACT Glaucoma is increasingly recognized not as a uniform pressure-defined optic neuropathy, but rather as a heterogeneous neurodegenerative disorder driven by interacting genetic, metabolic, mechanical, vascular, inflammatory, and environmental factors. Although genomics, transcriptomics, proteomics, and metabolomics have each yielded important insights, no single omics layer can […]

Topographic Ellipsoid Zone Reflectivity in Hereditary Optic Neuropathies

Invest Ophthalmol Vis Sci. 2026 Nov 2;67(13):38. doi: 10.1167/iovs.67.13.38. ABSTRACT PURPOSE: To quantitatively map topographic alterations in ellipsoid zone (EZ) optical coherence tomography signal intensity and investigate the subclinical photoreceptor involvement in hereditary optic neuropathies. METHODS: This retrospective, cross-sectional study included 170 eyes from 155 participants: 35 eyes with dominant optic atrophy, 35 with Leber […]

The expression level of PGAM5 regulates acute ocular hypertension-induced retinal ganglion cell injury

J Transl Med. 2026 Aug 25;24(1):1445. doi: 10.1186/s12967-026-08863-y. ABSTRACT BACKGROUND: Phosphoglycerate mutase 5 (PGAM5) is a critical regulator of mitochondrial quality control. This study aims to investigate the role of PGAM5 in retinal ganglion cells (RGCs) following acute ocular hypertension (AOH)-induced retinal ischemia-reperfusion (RIR) injury. METHODS: A mouse RIR model in vivo and an oxygen-glucose […]

Tear proteomics reveals reproducible pathway-level signatures of Parkinson’s disease pathogenesis

NPJ Parkinsons Dis. 2026 Aug 3;12(1):299. doi: 10.1038/s41531-026-01504-7. ABSTRACT Tear fluid is a promising minimally invasive biofluid for studying molecular alterations in neurodegenerative diseases. In this exploratory study, we applied a quantitative dia-PASEF nanoLC-MS/MS workflow to profile the tear proteome in idiopathic Parkinson’s disease (iPD), LRRK2-associated Parkinson’s disease (LRRK2-PD), and healthy controls. Protein identification and […]

Smoke, Not Smoking, as a Possible Risk Factor Triggering Conversion in Leber’s Hereditary Optic Neuropathy: A Retrospective Case Series

Am J Ophthalmol. 2026 Nov 19:S0002-9394(26)00620-3. doi: 10.1016/j.ajo.2026.11.011. Online ahead of print. ABSTRACT OBJECTIVE: To describe the association of wildfire smoke exposure with conversion of Leber hereditary optic neuropathy (LHON) mutation carriers to symptomatic LHON. DESIGN: In this retrospective observational case series, we performed an exploratory analysis of our institutional LHON registry for patients under […]

Silencing histone deacetylase 6 ameliorates retinal ischemia-reperfusion injury by inhibiting ferroptosis via regulating the HMGB1/NRF2 pathway

Tissue Cell. 2026 Nov 13;105:104137. doi: 10.1016/j.tice.2026.104137. Online ahead of print. ABSTRACT This study aimed to clarify the role of histone deacetylase 6 (HDAC6) in regulating ferroptosis via the high-mobility group box 1 (HMGB1)/nuclear factor erythroid 2-related factor 2 (NRF2) pathway in retinal ischemia-reperfusion injury (RIRI). In vitro, an ischemia/reperfusion (I/R) model was established in […]

Ptosis in Long-Term HIV Patients: A Clinical Marker of Mitochondrial Dysfunction and Surgical Management

Ophthalmic Plast Reconstr Surg. 2026 Nov 19. doi: 10.1097/IOP.0000000000003315. Online ahead of print. ABSTRACT BACKGROUND: Since the introduction of Highly Active Antiretroviral Therapy (HAART), human immunodeficiency virus (HIV) infection has transitioned from a fatal to a manageable chronic condition. However, long-term exposure to first-generation nucleoside reverse transcriptase inhibitors (NRTIs), including zidovudine, stavudine, didanosine, and zalcitabine, […]

Research Progress and Safety Controversies of Repeated Low-Level Red Light Therapy for Myopia Prevention and Control

J Ophthalmol. 2026 Nov 18;2026:9646505. doi: 10.1155/joph/9646505. eCollection 2026. ABSTRACT In recent years, the global prevalence of myopia has continued to rise. Complications associated with high myopia have become important risk factors for vision impairment, underscoring the need to identify safe and effective strategies for myopia prevention and control. Repeated low-level red light (RLRL) therapy, […]

VDAC1 oligomerization activates PANoptosis via mtDNA-STING axis in age-related macular degeneration

Free Radic Biol Med. 2026 Jan;242:150-166. doi: 10.1016/j.freeradbiomed.2025.10.285. Epub 2025 Oct 25. ABSTRACT Age-related macular degeneration involves the gradual degeneration of retinal pigment epithelium (RPE) cells. A better understanding of the molecular mechanism underlying RPE impairment is beneficial to the treatment of AMD. Here, we identify VDAC1 oligomerization as a critical initiator of RPE cell […]

A working model linking oxidative stress, histone H3K18 lactylation and ALKBH3 in age-related macular degeneration

Front Aging Neurosci. 2026 Nov 2;18:1949312. doi: 10.3389/fnagi.2026.1949312. eCollection 2026. ABSTRACT Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the elderly and is driven primarily by retinal pigment epithelium (RPE) dysfunction. Although oxidative stress and mitochondrial dysfunction are well-established early events in AMD, how these bioenergetic deficits relate to chronic […]